These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 36923215)
1. A cell cycle-related lncRNA signature predicts the progression-free interval in papillary thyroid carcinoma. Li S; Ran MY; Qiao H Front Endocrinol (Lausanne); 2023; 14():1110987. PubMed ID: 36923215 [TBL] [Abstract][Full Text] [Related]
2. A Potential Nine-lncRNAs Signature Identification and Nomogram Diagnostic Model Establishment for Papillary Thyroid Cancer. Yao JM; Zhao JY; Lv FF; Yang XB; Wang HJ Pathol Oncol Res; 2022; 28():1610012. PubMed ID: 35280112 [TBL] [Abstract][Full Text] [Related]
3. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911 [TBL] [Abstract][Full Text] [Related]
4. Analysis of the prognostic significance and potential mechanisms of lncRNAs associated with m6A methylation in papillary thyroid carcinoma. Huang Y; Li X; Chen W; He Y; Wu S; Li X; Hou B; Wang S; He Y; Jiang H; Lun Y; Zhang J Int Immunopharmacol; 2021 Dec; 101(Pt B):108286. PubMed ID: 34735975 [TBL] [Abstract][Full Text] [Related]
5. Golgi-apparatus genes related signature for predicting the progression-free interval of patients with papillary thyroid carcinoma. Liu R; Cao Z; Wu M; Li X; Fan P; Liu Z BMC Med Genomics; 2023 Mar; 16(1):60. PubMed ID: 36973751 [TBL] [Abstract][Full Text] [Related]
6. The role of lactate metabolism-related LncRNAs in the prognosis, mutation, and tumor microenvironment of papillary thyroid cancer. Xia M; Wang S; Wang L; Mei Y; Tu Y; Gao L Front Endocrinol (Lausanne); 2023; 14():1062317. PubMed ID: 37025405 [TBL] [Abstract][Full Text] [Related]
7. Identification of a Five-Gene Signature and Establishment of a Prognostic Nomogram to Predict Progression-Free Interval of Papillary Thyroid Carcinoma. Wu M; Yuan H; Li X; Liao Q; Liu Z Front Endocrinol (Lausanne); 2019; 10():790. PubMed ID: 31803141 [No Abstract] [Full Text] [Related]
8. Long noncoding RNA RP11-547D24.1 regulates proliferation and migration in papillary thyroid carcinoma: Identification and validation of a novel long noncoding RNA through integrated analysis of TCGA database. Guo K; Chen L; Wang Y; Qian K; Zheng X; Sun W; Sun T; Wu Y; Wang Z Cancer Med; 2019 Jun; 8(6):3105-3119. PubMed ID: 31044550 [TBL] [Abstract][Full Text] [Related]
9. Correlations of m Li X; Ding Z; Tong Y Int J Gen Med; 2024; 17():775-790. PubMed ID: 38476625 [TBL] [Abstract][Full Text] [Related]
10. STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway. Wen J; Wang H; Dong T; Gan P; Fang H; Wu S; Li J; Zhang Y; Du R; Zhu Q Cell Prolif; 2019 Mar; 52(2):e12569. PubMed ID: 30657221 [TBL] [Abstract][Full Text] [Related]
11. A Metabolic-associated Nomogram Predicts Recurrence Survival of Thyroid Cancer. Xi ZH; Ma XX; Chen HY; Yu YH; Li L; Huang T Curr Med Sci; 2021 Oct; 41(5):1004-1011. PubMed ID: 34510328 [TBL] [Abstract][Full Text] [Related]
12. Genomic Instability-Related LncRNA Signature Predicts the Prognosis and Highlights Dong X; Jin C; Chen D; Chen Y; Ye ZQ; Zhang X; Huang X; Zhang W; Gu DN Front Oncol; 2021; 11():737867. PubMed ID: 34604079 [TBL] [Abstract][Full Text] [Related]
13. Integrated analysis identifying new lncRNA markers revealed in ceRNA network for tumor recurrence in papillary thyroid carcinoma and build of nomogram. Chen F; Li Z; Deng C; Yan H J Cell Biochem; 2019 Dec; 120(12):19673-19683. PubMed ID: 31271223 [TBL] [Abstract][Full Text] [Related]
14. A pyroptosis-related lncRNA signature predicts prognosis and immune microenvironment in head and neck squamous cell carcinoma. Zhu W; Ye Z; Chen L; Liang H; Cai Q Int Immunopharmacol; 2021 Dec; 101(Pt B):108268. PubMed ID: 34688154 [TBL] [Abstract][Full Text] [Related]
15. Identification of lipid metabolism-related genes as prognostic indicators in papillary thyroid cancer. Wen S; Luo Y; Wu W; Zhang T; Yang Y; Ji Q; Wu Y; Shi R; Ma B; Xu M; Qu N Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1579-1589. PubMed ID: 34693452 [TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma. Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566 [TBL] [Abstract][Full Text] [Related]
17. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer. Song Y; Qu H BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619 [TBL] [Abstract][Full Text] [Related]
18. lncRNA DUXAP8 inhibits papillary thyroid carcinoma cell apoptosis via sponging the miR‑20b‑5p/SOS1 axis. Pang R; Yang S Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760128 [TBL] [Abstract][Full Text] [Related]
19. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis. Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405 [TBL] [Abstract][Full Text] [Related]
20. M7G-Related lncRNAs predict prognosis and regulate the immune microenvironment in lung squamous cell carcinoma. Pan J; Huang Z; Lin H; Cheng W; Lai J; Li J BMC Cancer; 2022 Nov; 22(1):1132. PubMed ID: 36333719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]